Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Safety and survival associated with biologic therapies: first report of the Biobadaguay on the Paraguayan-Uruguayan registry of adverse events with biologic therapies
Paloma de Abreu; Gabriela Ávila-Pedretti; Zoilo Morel; María Isabel Acosta; Sonia Cabrera-Villalba; Patricia Melgarejo; Marcos Franco; Pedro Delgadillo; Lourdes Román; Juan Gabriel Elizaur; Ernesto Paredes; Darwin Octavio Cordobilla; Daniel Palleiro; Miguel Albanese; Julio Mazzoleni;
Reumatol Clin. 2020;16P2:396-404
Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry
José Rosas; José Miguel Senabre-Gallego; Gregorio Santos-Soler; José Antonio Bernal; Ana Pons Bas;
Reumatol Clin. 2022;18:188-9
Clinical management and discontinuation of treatment in patients with recent onset rheumatoid arthritis in a rheumatology consultation
Zulema Rosales Rosado; Judit Font Urgelles; Isabel Hernández Rodríguez; Leticia León Mateos; Lydia Abásolo Alcázar; Juan Ángel Jover Jover;
Reumatol Clin. 2022;18:77-83